Comera Life Sciences to Go Public via Business Combination with OTR Acquisition Corp.

OceanTech Acquisitions I Corp and Captura Biopharma Sign Definitive Business Combination Agreement

August 10, 2022

Biotechnology

OceanTech Acquisitions I Corp., a special purpose acquisition company, signed a definitive merger agreement with Captura Biopharma to take the biotech company public. The combined company is expected to operate under the name Captura Biopharma Holdings, Inc. and remain listed on Nasdaq, subject to SEC, regulatory, and stockholder approvals.

TriSalus Life Sciences to Become Publicly Traded via Merger with MedTech Acquisition Corporation

November 14, 2022

Healthcare Services

TriSalus Life Sciences entered into a definitive merger agreement with MedTech Acquisition Corporation (MTAC), a Nasdaq-listed special purpose acquisition company, to take TriSalus public. The combined company expects to be listed on the Nasdaq under the ticker “TLSI,” with the transaction projected to close in Q1 2023 subject to regulatory approvals and customary closing conditions.

Voyager Acquisition Corp and VERAXA Biotech Announce Form F-4 Filing for Proposed Business Combination

July 17, 2025

Healthcare Services

VERAXA Biotech AG and Voyager Acquisition Corp. (a SPAC) have filed a Form F-4 registration statement with the SEC in connection with their proposed business combination announced in April 2025. Under the terms, VERAXA shareholders are expected to roll over 100% of their equity and receive approximately 130 million ordinary shares of the combined company, with the deal expected to close in Q4 2025.

Complete Solaria to Go Public via Business Combination with Freedom Acquisition I Corp

October 3, 2022

Cloud & SaaS

Complete Solaria entered into a definitive business combination agreement with Freedom Acquisition I Corp. to list on the NYSE under the ticker “CSLR,” expected to close in the first half of 2023. The transaction provides gross proceeds of up to approximately $376 million and is positioned to scale Complete Solaria’s U.S. residential solar model through end-to-end technology, financing, and service.

CareDx Acquires OTTR Complete Transplant Management

April 25, 2019

Healthcare Services

CareDx, Inc. agreed to acquire OTTR Complete Transplant Management, a provider of organ transplant patient-tracking software used by transplant centers in the US and Canada. The strategic acquisition (approximately $16.0 million) will integrate OTTR's EMR-integrated transplant management tools with CareDx's transplant diagnostics to streamline ordering and patient surveillance.

Alora Pharmaceuticals Acquires Osmotica's Legacy U.S. Business

August 30, 2021

Pharmaceuticals

Alora Pharmaceuticals, LLC closed the acquisition of Osmotica Pharmaceuticals plc's legacy U.S. business (including Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC and Trigen Laboratories, LLC) and the Marietta, Georgia manufacturing facility on August 27, 2021. Osmotica received approximately $111 million in proceeds, which it said would be used to retire a substantial portion of outstanding debt and to focus the company on its ophthalmic product UPNEEQ.